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Abstract 
Background: Nanomedicine offers a promising tool for therapies of brain diseases, but potential effects on neu‑
ronal health and neuronal differentiation need to be investigated to assess potential risks. The aim of this study was 
to investigate effects of silica‑indocyanine green/poly (ε‑caprolactone) nanoparticles (PCL‑NPs) engineered for laser 
tissue soldering in the brain before and during differentiation of SH‑SY5Y cells. Considering adaptations in mitochon‑
drial homeostasis during neuronal differentiation, metabolic effects of PCL‑NP exposure before and during neuronal 
differentiation were studied. In addition, kinases of the PI3 kinase (PI3‑K/Akt) and the MAP kinase (MAP‑K/ERK) path‑
ways related to neuronal differentiation and mitochondrial function were investigated.
Results: Differentiation resulted in a decrease in the cellular respiration rate and the extracellular acidification rate 
(ECAR). PCL‑NP exposure impaired mitochondrial function depending on the time of exposure. The cellular respiration 
rate was significantly reduced compared to differentiated controls when PCL‑NPs were given before differentiation. 
The shift in ECAR was less pronounced in PCL‑NP exposure during differentiation. Differentiation and PCL‑NP expo‑
sure had no effect on expression levels and the enzymatic activity of respiratory chain complexes. The activity of the 
glycolytic enzyme phosphofructokinase was significantly reduced after differentiation with the effect being more pro‑
nounced after PCL‑NP exposure before differentiation. The increase in mitochondrial membrane potential observed 
after differentiation was not found in SH‑SY5Y cells exposed to PCL‑NPs before differentiation. The cellular adenosine 
triphosphate (ATP) production significantly dropped during differentiation, and this effect was independent of the 
PCL‑NP exposure. Differentiation and nanoparticle exposure had no effect on superoxide levels at the endpoint of 
the experiments. A slight decrease in the expression of the neuronal differentiation markers was found after PCL‑NP 
exposure, but no morphological variation was observed.
Conclusions: PCL‑NP exposure affects mitochondrial function depending on the time of exposure before and during 
neuronal differentiation. PCL‑NP exposure during differentiation was associated with impaired mitochondrial func‑
tion, which may affect differentiation. Considering the importance of adaptations in cellular respiration for neuronal 
differentiation and function, further studies are needed to unravel the underlying mechanisms and consequences to 
assess the possible risks including neurodegeneration.
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Background
Nanomedicine offers promising possibilities for therapy 
of brain diseases as drug carriers, in tumor destruction 
and laser tissue soldering. In the latter application, silica 
nanoparticles embedded with bovine serum albumin in 
a biodegradable implant can be used for treatment of 
aneurysms in the brain [1, 2]. Despite several advantages 
compared to the conventional technique of suturing 
including speed, immediate water tightness, reduced tis-
sue trauma, and faster wound healing, the nanoparticles 
may cause potential adverse effects once released from 
the biodegradable scaffold.
In previous studies, nanoparticle uptake and the under-
lying mechanisms and effects of these silica nanoparticles 
were studied in microglial cells, primary hippocampal 
cultures, neuron-like cells (SH-SY5Y) and organotypic 
brain slices [3–5]. Nanoparticle exposure did not result 
in increased cytotoxicity and apoptosis in microglial and 
neuron-like cell lines even though a transient depletion 
of glutathione was found indicating reactive oxygen spe-
cies (ROS) formation [3]. Moreover, nanoparticles were 
demonstrated to be taken up by microglial cells in a 
time- and particle-dependent manner [4]; the uptake in 
primary hippocampal cultures was time- and concentra-
tion-dependent [5]. For all brain cells analyzed, no modu-
lation of inflammatory cytokine secretion and autophagy 
was observed [4, 5], but neuronal differentiation markers 
including mitogen-activated protein kinase/extracellular 
signal-related kinase (MAP-K/ERK) 1/2 and phosphati-
dyl-inositol 3-kinase/serine/threonine specific protein 
kinase (PI3-K/Akt) kinases were shown to be downregu-
lated after nanoparticle exposure [5].
Mitochondrial dynamics, trafficking, turnover, and bio-
genesis play key roles in regulating the functional health 
of neurons. Mitochondria do not only support the energy 
demands of neuronal electrophysiology, but also medi-
ate calcium homeostasis, integration of cell death/sur-
vival signals, and fatty acid metabolism [6]. The limited 
glycolytic potential and uncontrolled mitophagy were 
demonstrated to be linked to neurodegeneration with 
the protein kinases ERK1/2 and PTEN-induced kinase 1 
(PINK1) being involved [6]. Not surprisingly, perturba-
tions in mitochondrial function have long been centrally 
implicated in the pathogenesis of Parkinson’s disease [7, 
8].
Mitochondria play an important role in cell metabo-
lism during neuronal differentiation because this pro-
cess requires metabolic adaptations [9], and the PI3-K/
AKT and ERK pathways were reported to be required 
for the differentiation of retinoic acid (RA)—induced 
neuroblastoma cell differentiation [10]. MAP-K/ERK 1/2 
was reported to be important for regulating mitochon-
drial function [11–13] as well as PI3-K/Akt/mechanistic 
target of rapamycin (mTOR) being a regulator in glucose 
metabolism during neuronal differentiation [14]. Phos-
phorylation of c-Jun N-terminal kinase (JNK), ERK and 
p38 mitogen-activated kinase (p38) were found in pri-
mary astrocytes after exposure to zinc oxide (ZnO) nano-
particles [15]. Silver nanoparticles have demonstrated to 
induce impairment of mitochondrial oxidative phospho-
rylation [16] and exposure to titanium dioxide  (TiO2) 
nanoparticles significantly impaired mitochondrial func-
tion in a concentration- and time-dependent manner in 
astrocytes [17]. Silica nanoparticles effectively inhibited 
vascular endothelial growth factor (VEGF)—induced 
angiogenesis in vitro and ERK 1/2 activation [18].
Unlike other cells, neurons show limited glycolytic 
potential, and both insufficient and excessive mitophagy 
have been linked to neurodegeneration. Mitochondrial 
dynamics is important for neurogenesis and neuronal dif-
ferentiation [9, 19].
An increase in glucose metabolism was demonstrated 
during neuronal differentiation with PI3K/Akt/mTOR 
signaling being a critical regulator in neuronal energy 
metabolism [14]. Activated MAP-Ks were shown to 
phosphorylate various transcription factors resulting in 
regulation of cell proliferation, differentiation, inflam-
matory responses, oxidative stress caused by ROS and 
apoptosis [20]. Kinases have been demonstrated to be 
involved in neurite elongation (PI3-K/Akt), neuronal sur-
vival and in synaptic plasticity (MAP-K/ERK) of neurons 
[21, 22]. Activation of kinases such as Akt and ERK and 
an increase in neuronal differentiation was shown after 
exposure of SH-SY5Y cells to silver nanoparticles [23].
Given the importance of mitochondrial function in 
neuronal health, an interaction with nanoparticles may 
have detrimental consequences. Our aims were to inves-
tigate the effects of poly-(ε-caprolactone) (PCL) silica 
nanoparticles on the respiratory capacity of differentiat-
ing SH-SY5Y cells and to analyze the effect of nanopar-
ticle exposure on the expression and the activation of the 
protein kinases Akt and MAP-K before and during neu-
ronal differentiation.
Methods
Cell culture
SH-SY5Y cells were obtained from ATCC (Manassas, VA, 
USA), and culturing as well as differentiation was done 
with some adaptations as previously described [5]. Briefly, 
at day in vitro (DIV) 0, SH-SY5Y cells were seeded at a den-
sity of 1 × 107 cells per T75 for Western samples, 8 × 104 
cells per well in 24-well plates (Techno Plastic Products 
AG (TPP) Trasadingen, Switzerland) and maintained 
at non-differentiated state for 24  h in Dulbecco’s Modi-
fied Eagle Medium (DMEM) GlutaMAX™ medium (Life 
Technologies, UK) sodium pyruvate [1 mM], l-glutamine 
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[2  mM], penicillin/streptomycin ([1 unit/ml], Life Tech-
nologies, UK) at 37 °C in an atmosphere of 5%  CO2.
For the first 3 days of differentiation, cells were exposed 
to the same medium with a reduced FBS concentration 
(5%) and supplemented with retinoic acid [10 μM] (RA, 
Sigma, St Louis, USA). For the last 3  days, SH-SY5Y 
cells were grown in DMEM with only 1% FBS with RA 
[10  μM]. PCL-NP exposure was performed before dif-
ferentiation (NP DIFF) or during differentiation (DIFF 
NP DIFF) on DIV1 or DIV4, respectively. The cells were 
exposed to PCL-NPs in the same medium supplemented 
with 1% FBS for 24 h.
Nanoparticle exposure
Nanoparticle synthesis and characterization as well as 
the chemical and physical properties of the PCL-NPs 
have been described previously [3, 4, 24]. Briefly, a core 
shell nanoparticle system was developed consisting of 
a defined silica-core of 80  nm with a hydrophobic PCL 
coating acting as carrier system for ICG. The ICG dye was 
used as an absorbing dye for the laser-soldering proce-
dure. These nanoparticles incorporating rhodamine dye 
in the silica-core (silica-RITC)-PCL were used to study 
their uptake into cells. The designed nanoparticles were 
characterized by scanning electron microscopy, infrared 
spectroscopy, dynamic light scattering, thermogravimet-
ric analysis, fluorescence measurements, and two-photon 
microscopy. Size, shape, ICG concentrations, zeta poten-
tial (−25.4  mV), surface charge, surface chemistry and 
photo stability were evaluated and published previously 
[24]. A stock solution of [2.6  ×  1011 PCL-NPs/ml] was 
prepared using 0.0025% DMSO (Sigma, USA) in Dulbec-
co’s phosphate buffered saline (DPBS, Gibco, Life Tech-
nologies, UK). The stock solution was sonicated three 
times for 5 min with cooling steps in between to enable 
homogeneous nanoparticle suspension just before treat-
ment of the cells. The final concentration of PCL-NPs 
[2.6  ×  1010 PCL-NPs/ml] used for all experiments was 
obtained by dilution of the stock with culture medium 
containing 1% FBS as previously reported [4, 5].
Microplate‑based respirometry
The mitochondrial oxygen consumption rate (OCR), 
which is a key metric of aerobic mitochondrial function, 
and the extracellular acidification rate (ECAR), which 
approximates glycolytic activity, were analyzed simulta-
neously using a standard mitochondrial stress test para-
digm on the Seahorse Bioscience XF-24 analyzer (Agilent 
Technologies, CA, USA). Cells were assayed at DIV8 for 
OCR and ECAR measurements following the manufac-
turer’s instructions (Agilent Technologies, CA, USA). 
For each group, five independent experiments were per-
formed with five samples per experiment.
Before analysis, cells were washed three times with 
unbuffered assay media [DMEM (Sigma, Switzerland) 
diluted in water without phenol red supplemented 
with Glutamax (1X), sodium pyruvate [1  mM] and 
glutamine [2  mM], penicillin-streptomycin cocktail 
(1X) (Life Technologies, UK)] and incubated 1  h in a 
 CO2-free incubator at 37  °C. After the initial measure-
ment of basal OCR and ECAR, sequential exposures 
to modulators of mitochondrial activity were injected 
in the microtiter plate. First, the inhibitor of ATP syn-
thase oligomycin [1  µM] was added to determine leak 
respiration induced through passive proton leakage 
across the mitochondrial inner membrane. Next, the 
uncoupler of mitochondrial oxidative phosphorylation 
carbonyl cyanide-4-(trifuoromethoxy) phenylhydra-
zone (FCCP, [0.125 µM]) was added to assess maximally 
stimulated uncoupled respiration. Finally, the complex 
(C)III inhibitor, antimycin A [1  µM] together with CI 
inhibitor rotenone [1  µM], an inhibitor of mitochon-
drial NADH dehydrogenase, were added to determine 
extramitochondrial respiration. Optimal concentrations 
of oligomycin, FCCP, antimycin A and rotenone were 
determined before. Basal respiration or acidification was 
calculated using the mean of the four OCR or ECAR 
measurements before the first injection. Leak respiration 
and maximal respiration were calculated as the mean 
of three OCR measurement cycles after oligomycin or 
FCCP injection, respectively. Maximal acidification 
was calculated as the mean of three ECAR measure-
ment cycles after oligomycin injection. OCR data were 
corrected for non-mitochondrial oxygen consumption 
under rotenone and antimycin A. After each experi-
ment, cell numbers in each well were measured using 
the CyQUANT kit (Molecular Probes, OR, USA). OCR 
(pmol/min) and ECAR (mpH/min) values were normal-
ized to corresponding cell numbers.
Enzymatic activities of respiratory chain complexes
SH-SY5Y cells were cultured as described above and har-
vested on DIV8. Briefly, cells were washed twice in cold 
HBSS, scraped and centrifuged at 4  °C at 2000  rpm for 
5 min. Dried cell pellets were then frozen at −80 °C until 
used. For respiratory chain enzyme activity measure-
ments, cells were mechanically homogenized and soni-
cated in buffer containing [25 mM] potassium phosphate 
(pH 7.2), [5 mM]  MgCl2, and [2.5 mg/ml] BSA. Activity 
measurements of reduced nicotinamide adenine dinu-
cleotide (NADH) coenzyme Q reductase complex (C)
I, succinate dehydrogenase (CII), ubiquinol-cytochrome 
c reductase (CIII), cytochrome c oxidase (CIV), Mg-
ATPase (CV), and citrate synthase were determined 
separately by spectrophotometry as previously described 
[25].
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Phosphofructokinase activity (PFK)
Phosphofructokinase measurements were done 
according to the manufacturer’s datasheet (Phospho-
fructokinase Activity Colorimetric Assay Kit, Sigma, 
Switzerland). SH-SY5Y cells were seeded in T25 flasks 
(Techno Plastic Products AG (TPP), Trasadingen, Swit-
zerland) at a density of 3 × 106 cells per flask and treated 
as previously described above. Briefly, the protein was 
extracted by scraping off cells in 1 mL HBSS and centri-
fuged at 13.200×g for 10  min. The buffer was removed 
and the pellet was dissolved in 200  µL cold PFK assay 
buffer and centrifuged at 13.200×g for 10 min. The pel-
let was solubilized in 60  µL cold PFK buffer and 50  µL 
were transferred to a 96- well plate and a master mix 
consisting of PFK Assay Buffer, PFK Enzyme Mix, PFK 
Developer, ATP and PFK substrate was added. The 
absorbance (450 nm) was measured using a Synergy H1 
multi-mode reader. The data were compared with the 
NADH standard curve ranging from [2 to 10 nmol]/well 
and values were normalized to 1 mg protein. The protein 
amount of each sample was determined with Pierce™ 
660 nm Protein Assay Reagent (Thermo Fisher Scientific, 
Switzerland).
Mitochondrial membrane potential
The mitochondrial membrane potential (ΔΨm) was 
determined using tetramethylrhodamine methyl ester 
(TMRM, Invitrogen, Thermo Fisher Scientific, Swit-
zerland), a lipophilic cationic fluorescent probe which 
accumulates within mitochondria depending on their 
ΔΨm. The measurements were performed according 
to the supplier’s instructions. SH-SY5Y cells were cul-
tured as described above. Briefly, the provided Image-iT 
TMRM Reagent and TMRM were diluted to [100  nM] 
in 1%  FBS/DMEM medium. At DIV8, the medium was 
replaced with the staining solution for 30  min at 37  °C. 
Successively, the cells were washed twice with HBSS and 
the signal was measured at an emission of 488  nm and 
an extinction of 570 nm with a Synergy H1 multi-mode 
reader. Consequently, the protein amount of each sample 
was determined with OPA as described. The values were 
normalized to 1 mg protein.
Cellular ATP levels
The amount of intracellular ATP was determined with 
the CellTiter-Glo® Luminescent Cell Viability Assay (Pro-
mega AG, Switzerland). SH-SY5Y cells were seeded in a 
96-well plate at a density of 3.5 × 104 cells and cultured 
as described above. The measurements were performed 
according to the supplier’s datasheet. Shortly, the CellTi-
ter-Glo substrate was reconstituted in the CellTiter-Glo 
buffer and equilibrated to room temperature. Prior to 
the measurement (30  min) the plate was equilibrated 
to room temperature. The staining solution was added, 
mixed with an orbital shaker for 2 min and incubated in 
the dark for 10 min to stabilize the signal. Following, the 
luminescence was measured with a Synergy H1 multi-
mode reader with an integration time of 1 s. Finally, the 
protein amount of each sample was determined with 
OPA as described before. The values were normalized to 
1 mg protein.
Superoxide measurements
Mitochondrial superoxide was measured with the Mito-
SOX™ Red mitochondrial superoxide indicator for live 
cell imagining (Molecular Probes, Thermo Fisher Sci-
entific, Switzerland). SH-SY5Y cells were seeded in a 
96-well plate (Huberlab, Switzerland) at a density of 
3.5  ×  104 cells and cultured as described above. The 
measurements were done according to the supplier’s 
datasheet. Briefly, a [5  mM] stock solution of the pro-
vided MitoSOX reagent was prepared in DMSO and the 
stock solution was further diluted to a [5  µM] working 
solution in Hank’s balanced salt solution with calcium 
and magnesium (HBSS, Sigma, Switzerland). At DIV8, 
non-differentiated, differentiated as well as nanoparticle-
treated SH-SY5Y cells were incubated with [5 µM] Mito-
SOX working solution at 37 °C for 50 min after the cells 
were washed with HBSS. Fluorescence measurements 
were performed immediately at an emission of 510  nm 
and excitation of 580 nm with a Synergy H1 multi-mode 
reader (BioTek, Switzerland). Subsequently, the protein 
amount of each sample was determined using Fluoral-
dehyde™ o-phthaldialdehyde reagent solution (OPA, 
Thermo Fisher Scientific, Switzerland) at an emission of 
360 nm and an excitation of 460 nm. The results of the 
MitoSOX Assay were normalized to 1 mg protein.
Protein expression of differentiation markers and OXPHOS 
enzymes
SH-SY5Y cells were cultured as described above. On 
DIV7, protein extraction was performed and the samples 
were analyzed by Western Blot as described previously 
[5]. Briefly, SH-SY5Y cells were lysed in protein lysis 
buffer containing phosphatase (Sigma, Switzerland) and 
protease (Thermo ScientificTM, IL, Switzerland) cocktail 
inhibitors. The lysed cell suspension was incubated on 
ice for 15 min, sonicated for 10 s and finally centrifuged 
at high speed for 10 min at 4 °C. The protein content of 
the supernatant was quantified using the Pierce protein 
assay reagent (Bio-Rad Laboratories, CA, USA); 10  µg 
of protein from each test sample were loaded and subse-
quently separated on 12% SDS-PAGE before the protein 
was transferred onto PVDF membrane (Sigma, USA) 
at 0.25 A for 1.5  h (PI3- and ERK-kinases, OXPHOS) 
or nitrocellulose membrane (Bio-Rad, Switzerland) at 
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0.35 A for 2 h (MAP-2) membranes. Blocking for 2 h in 
PBS 0.2% Tween, 5% milk was performed at room tem-
perature. Subsequently, the primary antibodies, rab-
bit anti-phospho-Akt (1:1000), rabbit anti-Akt (1:1000), 
mouse anti-phospho-pMAP-K (ERK1/2) (1:2000), mouse 
anti-pMAP-K (ERK1/2) (1:2000) all from Cell Signaling 
Technology (MA, USA); mouse anti-MAP-2 (1:500) and 
the monoclonal mouse antibody anti-β-actin (1:10,000) 
both from Sigma (MO, USA); mouse anti-OXPHOS 
cocktail (1:1000) from Abcam (UK) were added for 
overnight incubation at 4  °C. The secondary antibodies, 
donkey-anti-rabbit and donkey-anti-mouse horseradish 
peroxidase (Thermo ScientificTM, IL, USA) were applied 
accordingly at 1:10,000–1:20,000 for 2 h at room temper-
ature. Chemiluminescent substrate (Advansta Western 
Bright Sirius Chemiluminescent, Witec, Switzerland) was 
used and chemiluminescence was detected using a lumi-
nescent image analyzer (LAS-3000 Imaging System from 
Fuji, Japan). Blot quantification was performed using 
ImageJ analysis (NIH, Bethesda, USA) measuring the 
ratio between the intensity of the obtained band of a spe-
cific marker versus the corresponding band of actin using 
arbitrary units.
Neuronal differentiation
Immunofluorescence staining was performed at the end 
of the culture period as previously described [5]. Briefly, 
cultures were fixed with 4% paraformaldehyde, blocking 
was performed with 10% normal horse serum in 0.4% 
Triton-X PBS before the primary antibody mouse anti-β-
3-tubulin (1:500) (Sigma, Switzerland) was applied over-
night at 4 °C in 0.4% Triton-X PBS. Finally, the secondary 
antibody [Alexa Fluor donkey anti-mouse 488 nm, Alexa 
Fluor anti-goat 488  nm (1:250) (Molecular Probes, 
Thermo Fisher Scientific, Switzerland)] was applied. 
Cell nuclei were counterstained using Hoechst 333,342 
(1:10,000) (Molecular Probes, Thermo Fisher Scientific, 
Switzerland). Images were performed using a Zeiss Axio 
Imager Z1 coupled with an Apotome 1 (Carl Zeiss Vision 
Swiss AG, Feldbach, Switzerland).
Statistical analysis
Three to five independent experiments were performed 
for all parameters measured. Data at each stage were ana-
lyzed using a one-way ANOVA followed by Tukey’s mul-
tiple comparison to compare the means of all treatments 
with the respective controls (GraphPad Software Inc., La 
Jolla, USA). For the protein quantification, three to four 
independent experiments were performed in duplicates 
for all analyses. A one-way ANOVA followed by the Dun-
nett’s test was used for group comparisons. Data are pre-
sented as mean ±  standard error of the mean (SEM). p 
values ≤0.05 were considered significant.
Results
Oxygen consumption rate and extracellular acidification 
rate
To evaluate whether PCL-NP exposure before and dur-
ing differentiation affected mitochondrial function, the 
oxygen consumption rate (OCR) and the extracellular 
acidification rate (ECAR) were analyzed in differentiated 
and undifferentiated SH-SY5Y cells. As shown in Fig. 1, 
the differentiation process led to a significant reduction 
(26.2%, p ≤ 0.05) of basal OCR and a significant reduc-
tion (36.8%, p ≤  0.0001) of maximal respiration in SH-
SY5Y cells when compared to undifferentiated control. 
PCL-NP exposure starting before differentiation was 
associated with a significantly decreased basal OCR 
compared to undifferentiated controls as well as differ-
entiated controls (50.9 and 24.7%, respectively) as shown 
in Fig.  1b. Leak respiration was decreased compared to 
undifferentiated controls and differentiated controls, 
whereas maximal respiration was approximately the 
Fig. 1 The oxygen consumption rate (OCR) was measured using 
a Seahorse Biosciences XF24 Analyser in SH‑SY5Y neuroblastoma 
cells exposed to PCL‑NPs for 24 h before differentiation (NP DIFF) 
or during differentiation (DIFF NP DIFF) on day in vitro (DIV) 1 and 
DIV4, respectively. Untreated SH‑SY5Y cells, either non‑differentiated 
(CO UNDIFF) or differentiated for 6 days (CO DIFF), were analyzed in 
parallel (a, b). SH‑SY5Y cells were exposed sequentially to each mito‑
chondrial modulator of mitochondrial activity (oligomycin = Oligo, 
FCCP and rotenone/antimycin A = Rot, AntiA). The mean ± SEM of 
the mitochondrial stress test on OCR are depicted over time (a). A 
quantitative analysis of the data is depicted in (b). Values represent 
the mean + SEM; n = 5 replicates of five independent experiments. 
*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001
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same as in differentiated control cells, but lower com-
pared to undifferentiated control cells.
The PCL-NP exposure initiated on the third day of dif-
ferentiation resulted in a non-significant decrease (3.25%) 
in OCR as compared to undifferentiated controls, but a 
significant increase of 22.9% when compared to differen-
tiated controls (p ≤ 0.05) (Fig. 1b). Leak respiration and 
maximal respiratory capacity were significantly lower 
compared to undifferentiated controls, but significantly 
higher compared to differentiated control cells (Fig. 1b).
The maximal respiratory capacity for SH-SY5Y cells 
exposed to PCL-NPs started during differentiation was 
significantly lower compared to undifferentiated controls 
(p ≤ 0.01), but significantly higher compared to differen-
tiated control cells (p ≤ 0.01) (Fig. 1b).
Under basal conditions, the ECAR was significantly 
decreased (41.4%) in differentiated cells compared to 
undifferentiated cells (p ≤ 0.001) as illustrated in Fig. 2a, 
b. The ECAR in cells exposed to PCL-NPs before and 
during differentiation was significantly lower compared 
to undifferentiated SH-SY5Y control cells with p ≤ 0.01 
and p  ≤  0.05, respectively (Fig.  2b). No difference was 
found between differentiated SH-SY5Y cells devoid of 
nanoparticles and PCL-NP exposed cells.
The inhibition of ATP synthesis initiated by oligomycin 
resulted in an increase in ECAR in all four groups due 
to the inhibition of mitochondrial ATPase with a similar 
pattern for maximal acidification. The increase was 1.8-
fold in undifferentiated cells and twofold in differentiated 
cells (p ≤ 0.01) as shown in Fig. 2.
The cellular metabolic phenotypes are summarized 
in Fig.  2c. Whereas undifferentiated SH-SY5Y cells are 
characterized by a high cellular OCR and ECAR, dif-
ferentiation process leads to a shift to lower OCR and 
ECAR levels. Exposures to nanoparticles before and dur-
ing neuronal differentiation induce significant changes 
in the described shift in energy metabolism (OCR and 
ECAR).
Fig. 2 The extracellular acidification rate (ECAR) was measured using a Seahorse Biosciences XF24 Analyser. The bioenergetic activity was analyzed 
in SH‑SY5Y neuroblastoma cells exposed to PCL‑NPs for 24 h before differentiation (NP DIFF) or during differentiation (DIFF NP DIFF) on day in vitro 
(DIV) 1 and DIV4, respectively. Untreated SH‑SY5Y cells, either non‑differentiated (CO UNDIFF) or differentiated for 6 days (CO DIFF), were analyzed in 
parallel (a, b). SH‑SY5Y cells were exposed sequentially to each mitochondrial modulator of mitochondrial activity (oligomycin, FCCP and rotenone/
actinomycin A). The mean ± SEM of the mitochondrial stress test on ECAR are depicted over time (a). A quantitative analysis of the data is depicted 
in (b). Values represent the mean + SEM; n = 5 replicates of five independent experiments. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001. The 
energy phenotype is depicted by ECAR on the x axis and the mitochondrial respiration is represented by the oxygen consumption rate (OCR) on 
the y axis. Bioenergetic profiling of SH‑SY5Y cells (OCR versus ECAR) revealed decreased metabolic activity after exposure to PCL‑NPs. Values repre‑
sent the raw mean ± SEM of each group (mean of the ECAR in abscissa/mean of the OCR in ordinate) (c)
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Expression and activity of mitochondrial respiratory chain 
enzymes
In order to gain more information about the mechanism 
of the observed decrease in OCR measurements, Western 
blot analyses of subunits of each enzyme complex were 
performed and enzymatic activities of all five respira-
tory chain complexes were quantified. As shown in Fig. 3, 
the protein content of selected subunits of enzyme com-
plexes I to V of the respiratory chain revealed no signifi-
cant change after PCL-NP exposure when compared to 
Fig. 3 Oxidative phosphorylation enzymes (OXPHOS) were analyzed to evaluate expression of mitochondrial chain complexes I to V in SH‑SY5Y 
cells exposed to PCL‑NPs ([2.6 × 1010 PCL‑NPs/ml]) for 24 h before (DIV1, NP DIFF) or after (DIV4, DIFF NP DIFF) differentiation with retinoic acid. 
Untreated controls, undifferentiated SH‑SY5Y cells (CO UNDIFF) and differentiated SH‑SY5Y cells (CO DIFF) were performed in parallel. The following 
complexes or subunits of the complexes were analyzed: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydroge‑
nase complex (C)I (CI‑NDUFB8); iron‑sulfur protein (IP) subunit of succinate dehydrogenase involved in CII (CII‑SDHB); component of the ubiquinol‑
cytochrome c reductase of CIII (CIII‑UQCRC2); catalytic subunit of cytochrome c oxidase of CIV (CIV‑ MTCO1), and mitochondrial membrane ATP 
synthase (F(1)F(0) ATP synthase) or CV (CV‑ATP5A). Representative Western blots are shown in (a). The histograms represent the ratio of each com‑
plex normalized to the corresponding actin (loading control) band CI (b), CII (c), CIII (d), CIV (e) and CV (f). Respective protein levels were assessed 
using digital quantification of immunoblots, and they are presented as relative intensity compared to total protein. The analysis was done using 
ImageJ. Values are expressed with arbitrary units. Error bars represent the mean + SEM
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undifferentiated or differentiated control cells. In accord-
ance, activity measurements of complexes I–V showed no 
significant variation (Table 1) independent of the cell dif-
ferentiation and the nanoparticle exposure time. 
Phosphofructokinase activity
Phosphofructokinase (PFK) activity in SH-SY5Y cells was 
found significantly decreased in differentiated controls 
in comparison to undifferentiated controls (p  ≤  0.05) 
(Fig. 4a). In contrast to nanoparticle exposure during dif-
ferentiation, nanoparticle exposure before differentiation, 
led to a significant decrease in PFK activity when com-
pared to differentiated controls (p ≤ 0.0001). PFK activity 
was also found to be significantly reduced in nanoparticle 
treated cells compared to undifferentiated control cells 
with the effect being more pronounced for nanoparticles 
applied before differentiation (Fig. 4a).
Mitochondrial membrane potential (ΔΨm), intracellular ATP 
and superoxide production
Mitochondrial membrane potential is a key indicator of 
the integrity of the membrane. As shown in Fig. 4b, dif-
ferentiation of SH-SY5Y cells led to a significant increase 
in ΔΨm compared to undifferentiated control cells 
(p ≤ 0.05) as well as nanoparticle exposure during differ-
entiation. In contrast, exposure to PCL-NPs before differ-
entiation resulted in a significant reduction in ΔΨm when 
compared to differentiated controls (p ≤ 0.0001) and to 
undifferentiated controls (p ≤ 0.01) (Fig. 4b).
As illustrated in Fig. 4c, significant differences in ATP 
production on DIV8 were observed between undiffer-
entiated controls and differentiated controls (p ≤ 0.001) 
and cells exposed to nanoparticles before differentiation 
(p ≤ 0.01) and during differentiation (p ≤ 0.001).
No significant variation in superoxide production was 
found when PCL-NP exposed groups and controls were 
compared (Fig. 5).
Effect of NP exposure on neuronal differentiation markers
Kinases have been demonstrated to be involved in neu-
rite elongation (PI3-K/Akt) and in synaptic plasticity 
(MAP-K/ERK) of neurons. Therefore, we investigated 
the effect of PCL-NP exposure on the expression of these 
kinases. A significant upregulation of the phosphorylated 
kinases Akt (P-Akt) (p ≤ 0.001) and MAP-K (P-p42/44-
MAP-K) (p  ≤  0.05) was found in differentiated cells 
compared to undifferentiated SH-SY5Y cells as shown 
in Fig. 6a–e. PCL-NP exposure for 24 h before differen-
tiation and during differentiation resulted in a significant 
upregulation of phosphorylated-Akt (P-Akt) (p  ≤  0.01) 
of the same magnitude when compared to undifferenti-
ated control SH-SY5Y cells on DIV6 (Fig. 6b). No differ-
ence between PCL-NP treated cells and differentiated 
control cells was found. Likewise, a decrease in both, 
P-p42-MAP-K and P-p44-MAP-K was seen in both PCL-
NP exposed conditions in SH-SY5Y cells when compared 
to differentiated control cells. However, this effect was 
not statistically significant (Fig. 6d, e).
Differentiated SH-SY5Y cells showed a significant 
increase in the differentiation marker MAP-2 (p ≤ 0.05) 
(Fig. 6f, g). Exposure to PCL-NPs before and during the 
differentiation resulted in a significant upregulation of 
this marker when compared to undifferentiated control 
cells (p ≤ 0.001 and p ≤ 0.01, respectively) as illustrated 
in Fig.  6g. The upregulation of MAP-2 after PCL-NP 
exposure was higher compared to differentiated controls, 
but the effect was not statistically significant.
Neuronal differentiation was analyzed using β-3-
tubulin-staining and differentiated cells displayed typi-
cal neuronal morphology (Fig. 7). Neurite outgrowth was 
observed when undifferentiated control cells (Fig. 7a) and 
differentiated controls (Fig.  7b) were compared. Nano-
particle exposure (Fig.  7c, d) did not result in obvious 
cellular morphological differences when compared to dif-
ferentiated control cells.
Discussion
A limited glycolytic potential has been linked to neuro-
degeneration and mitochondrial dynamics are important 
for neurodegeneration [9]. In contrast to astrocytes, neu-
rons were reported to exhibit lower levels of glycolysis 
[26].
Table 1 Enzymatic activities of respiratory chain complexes
Enzymatic activities of respiratory chain complexes were measured on day in vitro 8 (DIV8) in undifferentiated control cells (CO UNDIFF), differentiated control cells 
(CO DIFF) and PCL-NPs exposed cells before (NP DIFF) or during (DIFF NP DIFF) differentiation. Values were estimated by the difference in activity levels measured in 
presence and absence of specific inhibitors; values are expressed as ratios to the mitochondrial marker enzyme citrate synthase (mU/mU citrate synthase) ± S.E.M
Experimental group Citrate synthase activity
(mU/mg protein)
Enzymatic complex activities (mU/mU citrate synthase)
CI CII CIII CIV CV
CO DIFF 111 ± 7 0.1 ± 0.01 0.15 ± 0.01 0.13 ± 0.01 0.18 ± 0.01 0.39 ± 0.03
DIFF NP DIFF 131 ± 8 0.07 ± 0.01 0.14 ± 0.01 0.14 ± 0.01 0.13 ± 0.01 0.35 ± 0.03
NP DIFF 127 ± 9 0.08 ± 0.01 0.16 ± 0.02 0.14 ± 0.01 0.15 ± 0.01 0.37 ± 0.05
CO UNDIFF 118 ± 12 0.08 ± 0.01 0.14 ± 0.01 0.18 ± 0.02 0.13 ± 0.03 0.40 ± 0.04
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Differentiation of SH-SY5Y cells resulted in changes 
in the cellular metabolism. As expected, the OCR and 
the intracellular ATP levels were decreased in differen-
tiated SH-SY5Y cells compared to undifferentiated cells 
corroborating previous findings [27, 28]. Differenti-
ated SH-SY5Y cells were reported to exhibit an elevated 
stimulation of mitochondrial respiration indicating an 
increased mitochondrial reserve capacity compared to 
undifferentiated SH-SY5Y cells due to changes in mito-
chondrial metabolism [29, 30].
The basal OCR was significantly reduced after PCL-NP 
exposure before differentiation compared to differenti-
ated cells, whereas an increase in OCR was measured 
when PCL-NPs were added to the cells during differen-
tiation. Blockage or serious inhibition of the mitochon-
drial chain is detrimental for neuronal differentiation [31, 
32]. ZnO nanoparticles were reported to induce apopto-
sis and decrease the mitochondrial membrane potential 
in primary astrocytes indicating that mitochondria are 
involved in ZnO nanoparticle-induced apoptosis. The 
nanoparticle exposure resulted in phosphorylation of 
c-Jun N-terminal kinase (JNK), ERK, and p38 mitogen 
activated protein kinase (p38 MAP-K) [14]. Silver nano-
particles showed a decoupling effect on mitochondria 
resulting in an impairment of mitochondrial oxidative 
phosphorylation [16]. In agreement with the observed 
increase in basal cellular respiration in PCL-NPs expo-
sure during differentiation,  TiO2 nanoparticles increased 
the basal cellular respiration in human keratinocytes in a 
concentration-dependent manner [33].
In undifferentiated and differentiated SH-SY5Y con-
trol cells, a decrease in OCR occurred after the addition 
of the inhibitor of ATP synthase, oligomycin, with the 
drop being more pronounced in differentiated controls 
indicating that the mitochondrial oxygen consumption 
used for ATP synthesis increases during cellular differ-
entiation. The observed increase in mitochondrial mem-
brane potential in differentiated SH-SY5Y cells compared 
to undifferentiated cells has been described before [29]. 
The increase in membrane potential was also found after 
nanoparticle exposure during differentiation, whereas 
Fig. 4 Phosphofructokinase (PFK) activity (a), mitochondrial mem‑
brane potential (ΔΨm) (b) and ATP production (c) were assessed in 
SH‑SY5Y cells undifferentiated controls (CO UNDIFF), differentiated 
controls (CO DIFF) and exposed to PCL‑NPs before (NP DIFF) or during 
(DIFF NP DIFF) differentiation. The histograms represent values cal‑
culated as percent of undifferentiated controls. Values are expressed 
as milliunits/ml/mg protein for PKF activity (a), fluorescence intensity 
unit (FIU)/mg protein for ΔΨm (b), as luminescence/mg protein for 
ATP production (c). Error bars represent the mean + SEM. Significant 
differences to undifferentiated and differentiated controls are labeled 
with asterisks (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ***p ≤ 0.0001)
Fig. 5 Superoxide production was measured at DIV8 in SH‑SY5Y cells 
exposed to PCL‑NPs before (DIV1, NP DIFF) or during (DIV4, DIFF NP 
DIFF) differentiation with RA. Untreated controls, undifferentiated 
cells (CO UNDIFF) and differentiated cells (CO DIFF) were performed 
in parallel. Values are expressed as fluorescent intensity units (FIU)/
mg protein; they are represented as percentage of undifferentiated 
control. Error bars represent the mean + SEM
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nanoparticle exposure before differentiation resulted 
in a significant reduction of mitochondrial membrane 
potential indicating an impairment of mitochondrial 
metabolism. As the elevation in membrane potential has 
been demonstrated to be accompanied with differentia-
tion [29], the nanoparticle exposure might impair differ-
entiation. Silica-oxide nanoparticles were reported to 
reduce the membrane potential in hepatocytes [34], and 
a decrease in membrane potential was also demonstrated 
in human umbilical endothelial cells after exposure to 
60  nm silica nanoparticles [35] corroborating our find-
ings. Production of ATP by oxidative phosphorylation 
and especially dysfunction of this system has been related 
to the generation of superoxide, and its scavenging is 
accomplished by radical scavengers such as superoxide 
dismutase [6]. PCL-NPs exposure before differentiation 
decreased basal OCR significantly more compared to 
differentiated control cells. In contrast, PCL-NP expo-
sure during differentiation did not significantly change 
ATP production compared to differentiated control 
cells. Additional measurements showed that differen-
tiation induced a significant decrease in ATP levels, but 
nanoparticle exposure had no effect on this parameter. 
In addition, the expression and the activity of the mito-
chondrial chain complexes I to V was not affected by 
nanoparticle exposure. In contrast, silica oxide nano-
particles were demonstrated to reduce the mitochon-
drial chain complexes I, III and IV in rat hepatocytes 
[34]. The smaller size of these nanoparticles as well as 
the different cell type may explain the different findings. 
Fig. 6 Markers of the PI3 kinase pathways (PI3‑K/Akt), MAP kinase (MAP‑K/ERK), and of mature neurons (MAP‑2) were used to evaluate neuronal 
differentiation in SH‑SY5Y cells exposed to PCL‑NPs ([2.6 × 1010] PCL‑NPs/ml) for 24 h before (DIV1, NP DIFF) or during (DIV4, DIFF NP DIFF) dif‑
ferentiation with retinoic acid added until DIV7. Untreated controls, undifferentiated SH‑SY5Y cells (CO UNDIFF) and differentiated SH‑SY5Y cells 
(CO DIFF) were performed in parallel. Representative Western blots are shown in (a, c, f). The histograms represent the ratio of phosphorylated Akt 
(P‑Akt) (b) and phosphorylated p42/44‑MAP‑K (P‑p42/44‑MAP‑K) (d, e) to Akt and p42/44‑MAP‑K. A histogram of the ratio MAP‑2/actin is shown in 
(g). The actin signal was used as loading control. Respective protein levels were assessed using digital quantification of immunoblots, and they are 
presented as relative intensity compared to total protein. The analysis was done using ImageJ. Values are expressed with arbitrary units. Error bars 
represent the mean + SEM. Significant differences to undifferentiated and differentiated controls are labeled with asterisks (*p ≤ 0.05; **p ≤ 0.01; 
***p ≤ 0.001)
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Acute nanoparticle exposure might increase leak res-
piration if given to undifferentiated cells causing acute 
stress. Hence, they are more vulnerable to mitochon-
drial uncoupling. In agreement with this hypothesis, 
transient ROS production was found in undifferentiated 
SH-SY5Y cells [3]. Superoxide production did not vary 
between all groups in this study. Previously, an increase 
in ROS production was found in undifferentiated cells 
[3]. Silica nanoparticles were also reported to increase 
superoxide levels in the corpus striatum of rats [36] and 
inhibited superoxide dismutase in human endothelial 
cells [35]. However, the physicochemical differences and/
or the different species or cell type may explain the vari-
able findings. It needs to be noted that distinct energy 
metabolism profiles were found in pluripotent stem cells, 
differentiated cells and cancer cells [37]. Recently, it was 
demonstrated that changes in mitochondrial function 
after  Fe3O4 nanoparticle exposure were less pronounced 
in neuronal cells compared to astrocytes [38]. In the pre-
sent study, cells were differentiated and the superoxide 
was measured after the differentiation period. Hence, 
the discrepancy may be due to the differentiation of the 
cells and the time of the measurements. The production 
of oxygen radicals by HeLa cells and human hepatocytes 
after silica-quantum dots exposure was reported to reach 
a plateau already 40 min after exposure [39]. An increase 
in superoxide cannot be excluded in our study as it might 
have occurred right after the nanoparticle exposure or 
before the end of the differentiation period.
The uncoupled maximal respiration (OCR under 
FCCP) was significantly higher in undifferentiated cells 
compared to differentiated cells. PCL-NP exposure 
before differentiation did not change maximal respira-
tion, whereas PCL-NP exposure during differentiation 
significantly increased maximal respiration compared 
to differentiated control cells.  TiO2 nanoparticle expo-
sure was demonstrated to change mitochondrial mem-
brane potential in rat primary hippocampal neurons 
[40], induce neuronal dysfunction in primary astrocytes 
[41], and decrease the activity of all mitochondrial res-
piratory chain complexes in brain tissue [42]. These 
findings corroborate our data despite the different com-
position of nanoparticles. In contrast,  TiO2 nanoparti-
cles were reported to increase the OCR after rotenone 
Fig. 7 Representative microscopic images showing morphological features of SH‑SY5Y cells, undifferentiated controls (a), differentiated controls 
(b) and exposed to NPs before (c) or during differentiation (d). At the end of the differentiation (DIV8), cells were stained with the neuronal marker 
β‑3‑tubulin (green), NPs appear in red (RITC labeling) and cell nuclei were counterstained with Hoechst (blue). The arrows depict neurites from dif‑
ferentiated neurons. Magnification 400×. Inserts demonstrate higher magnification of the square in the picture. Scale bars 10 μm
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in keratinocytes [33]. Different material, size and charge 
of the nanoparticles and the difference in cell origin may 
account for this difference.
Mitochondria play an important role in cell metabo-
lism during neuronal differentiation because neuronal 
cell differentiation requires metabolic adaptations [9]. 
A lower glycolytic activity was found in differentiated 
cells compared to undifferentiated cells, and PCL-NP 
exposure, independent of the time of exposure, was not 
significantly different from differentiated cells but sig-
nificantly reduced compared to undifferentiated controls. 
Carbon monoxide supplementation was demonstrated 
to promote metabolic changes occurring during neu-
ronal differentiation, namely, from glycolytic to oxida-
tive metabolism [9]. Measurements of the activity of 
the key enzyme in glycolysis, PFK, showed a significant 
reduction between differentiated control cells and undif-
ferentiated cells. PFK levels of cells exposed to PCL-NPs 
during differentiation did not vary compared to differen-
tiated controls, but PFK levels were significantly reduced 
in cells where nanoparticles were given before differen-
tiation. Cell differentiation was reported to be associ-
ated with metabolic changes and a metabolic shift from 
glycolysis to oxidative phosphorylation during neuronal 
differentiation has been demonstrated [19]. Moreover, 
artificial constitutive expression of hexokinase and lactate 
dehydrogenase was shown to result in cell death indicat-
ing that a decrease in glycolysis is essential for neuronal 
differentiation [43]. Thus the observed reduction of PFK 
activity in cells exposed to PCL-NPs before differentia-
tion may affect differentiation. In contrary, an increase in 
glucose metabolism was found during neuronal differen-
tiation with PI3-K/Akt/mTOR signaling being a critical 
regulator [14].
Neuronal differentiation
Kinases such as PI3-K/Akt and MAP-K/ERK are involved 
in neurite elongation, neuronal survival and synap-
tic plasticity of neurons [10, 21–23], and MAP-K/ERK 
was demonstrated to play a key role in mitochondrial 
function [44]. Recent data demonstrate that prolifera-
tive neuronal stem cells have high ROS levels, which is 
required for self-renewal and neurogenesis with under-
lying PI3-K/Akt signaling [45]. A significant increase 
in the differentiation markers (PI3-K/Akt and MAP-K/
ERK) was found in differentiated SH-SY5Y compared to 
undifferentiated cells indicating that these kinases are 
involved in neuronal differentiation [46]. This finding is 
corroborating previously published data [5] and other 
studies also demonstrated that the PI3-K/Akt improved 
neurite elongation in primary hippocampal and cortical 
neurons [21, 22, 47]. However, PCL-NP exposure before 
and during differentiation did not significantly change 
the expression of both kinases. In contrast, recently pub-
lished results demonstrated a significant reduction of the 
differentiation markers used in this study, but neurite 
outgrowth was not significantly altered by exposure to 
PCL-NPs for 24 h before differentiation in SH-SY5Y cells 
[5]. The disparate findings may be explained by the dif-
ferentiation protocol used in the current study as com-
pared to the previous work; namely, a moderate FBS 
starvation during RA treatment. Starvation was only 
initiated after DIV3 (1% FBS) and the cells were incu-
bated with 5% FBS for the first 3 days of differentiation. 
The expression of the neuronal marker MAP-2 was sig-
nificantly increased in differentiated control cells and in 
cells exposed to PCL-NPs either before or during dif-
ferentiation. Previously published data demonstrated a 
significantly reduced expression of MAP-2 in SH-SY5Y 
cells exposed to PCL-NP for 24  h before differentiation 
supporting this hypothesis. However, the trend towards 
a reduced expression of PI3-K/Akt and MAP-K/ERK was 
also found in the present study. In contrast to these find-
ings, an activation of the kinases Akt and ERK after expo-
sure to silver nanoparticles, enhanced neurite outgrowth, 
an increase in MAP-2 and an increased ROS produc-
tion was reported [23]. ERK induction was found to be 
involved in mitochondrial degradation in SH-SY5Y cells 
used in an in vitro model for Parkinson disease with its 
activity being important for microphagy [48, 49].
The size (30 vs. 80 nm) and the different material may 
explain the disparate findings. Silica nanoparticles were 
shown to cause oxidative stress in endothelial cells via 
activation of the MAP-K/Nrf2 pathway and nuclear fac-
tor-kappaB signaling [50]. The same authors reported 
that amorphous silica nanoparticles induced ROS pro-
duction mediated by MAP-K/Bcl-2 and PI3-K/Akt/
mTOR signaling in endothelial cells. In that study, phos-
phorylated ERK, PI3-K/Akt, and mTOR were signifi-
cantly decreased, whereas phosphorylated JNK and p38 
MAP-K were increased after exposure to silica nanopar-
ticles [51]. Despite the different cell origin, in our study, 
a decreased PI3-K/Akt and phosphorylated p42/44-
MAP-K was found after PCL-NP exposure before and 
during differentiation in SH-SY5Y cells even though the 
effect was not statistically significant. As reported pre-
viously, PCL-NP exposure increased ROS production 
only transiently in SH-SY5Y cells [3]. Oxidative stress 
was demonstrated to activate MAP-K pathways [20]. 
Silver nanoparticles were shown to result in an increase 
in ROS and an activation of ERK and Akt supporting 
neuronal differentiation in SH-SY5Y cells. This was also 
demonstrated by an increased expression of the neuronal 
differentiation marker MAP-2 [23]. This finding is in 
agreement with our data, where PCL-NP exposure led to 
slightly increased levels of MAP-2.
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Conclusions
PCL-NP exposure of SH-SY5Y cells affected mitochon-
drial function and the expression of differentiation mark-
ers in a time-dependent manner during differentiation. 
Considering the importance of adaptations in cellular 
respiration for neuronal differentiation and function, 
further studies addressing the regulation and the func-
tional impact of PCL-NP exposure are needed to unravel 
the underlying mechanisms and consequences to assess 
the possible risks for using them in biomedical applica-
tions as impaired mitochondrial function may lead to 
neurodegeneration.
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